Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2024;6(4):148-153.
doi: 10.33696/cancerimmunol.6.095.

A Blood-based Metabolite Signature for Personalized Risk Assessment of Pancreatic Cancer

Ricardo A León-Letelier  1 , Yihui Chen  1 , Riccardo Ballaro  1 , Ehsan Irajizad  2 , Kim-An Do  2 , Anirban Maitra  3 , Jianjun Zhang  4 , C Max Schmidt  5 , Johannes F Fahrmann  1
Affiliations
Comment

A Blood-based Metabolite Signature for Personalized Risk Assessment of Pancreatic Cancer

Ricardo A León-Letelier et al. J Cancer Immunol (Wilmington). 2024.
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
A stepwise strategy of identifying individuals at high-risk of developing PDAC (Phase 1) who would benefit from surveillance and screening (Phase 2) with pertinent cancer detection tests (e.g. CA19–9) that would trigger an imaging-based modality, such as CT/MRI, and diagnostic work-up (Phase 3) for earlier detection of PDAC. Created with Biorender.com.
See this image and copyright information in PMC

Comment on

  • A blood-based metabolomic signature predictive of risk for pancreatic cancer.
    Irajizad E, Kenney A, Tang T, Vykoukal J, Wu R, Murage E, Dennison JB, Sans M, Long JP, Loftus M, Chabot JA, Kluger MD, Kastrinos F, Brais L, Babic A, Jajoo K, Lee LS, Clancy TE, Ng K, Bullock A, Genkinger JM, Maitra A, Do KA, Yu B, Wolpin BM, Hanash S, Fahrmann JF. Irajizad E, et al. Cell Rep Med. 2023 Sep 19;4(9):101194. doi: 10.1016/j.xcrm.2023.101194. Cell Rep Med. 2023. PMID: 37729870 Free PMC article.

References

    1. Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12–49. - PubMed
    1. Rahib L, Wehner MR, Matrisian LM, Nead KT. Estimated Projection of US Cancer Incidence and Death to 2040. JAMA Netw Open. 2021;4(4):e214708. - PMC - PubMed
    1. Lippman SM, Abate-Shen C, Colbert Maresso KL, Colditz GA, Dannenberg AJ, Davidson NE, et al. AACR White Paper: Shaping the Future of Cancer Prevention - A Roadmap for Advancing Science and Public Health. Cancer Prev Res (Phila). 2018. Dec;11(12):735–78. - PMC - PubMed
    1. Singhi AD, Koay EJ, Chari ST, Maitra A. Early Detection of Pancreatic Cancer: Opportunities and Challenges. Gastroenterology. 2019;156(7):2024–240. - PMC - PubMed
    1. US Preventive Services Task Force; Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, et al. Screening for Pancreatic Cancer: US Preventive Services Task Force Reaffirmation Recommendation Statement. JAMA. 2019. Aug 6;322(5):438–44. - PubMed

LinkOut - more resources